References and Notes
For reviews concerning lignans, see:
1a
MacRae WD.
Towers GHN.
Phytochemistry
1984,
23:
1207
1b
Whiting DA.
Nat. Prod. Rep.
1987,
4:
499
1c
Ward RS.
Nat. Prod. Rep.
1993,
10:
1
1d
Ward RS.
Nat. Prod. Rep.
1995,
12:
183
1e
Ward RS.
Nat. Prod. Rep.
1997,
14:
43
1f
Ward RS.
Nat. Prod. Rep.
1997,
16:
75
For reviews on the strategies of oxacycle synthesis, see:
2a
Faul MM.
Huff BE.
Chem. Rev.
2000,
100:
2407
2b
Elliott MC.
J. Chem. Soc., Perkin Trans. 1
2002,
2301
For methods resulting in a total synthesis of a furofuran lignan, see:
3a
Takano S.
Samizu K.
Ogasawara K.
Synlett
1993,
785
3b
Akindele T.
Marsden SP.
Cumming JG.
Org. Lett.
2005,
7:
3685
3c
Wardrop DJ.
Fritz J.
Org. Lett.
2006,
8:
3659
3d Review: Brown R.
Swain NA.
Synthesis
2004,
811
4a
Cassidy JH.
Marsden SP.
Stemp G.
Synlett
1997,
1411
4b
Miles SM.
Marsden SP.
Leatherbarrow RJ.
Coates WJ.
J. Org. Chem.
2004,
69:
6874
5a
Zhang Y.
Reynolds NT.
Manju K.
Rovis T.
J. Am. Chem. Soc.
2002,
124:
9720
5b
Zhang Y.
Rovis T.
Tetrahedron Lett.
2003,
59:
8979
5c
Nasveschuk CG.
Rovis T.
Org. Lett.
2005,
7:
2173
5d
Nasveschuk CG.
Rovis T.
Angew. Chem. Int. Ed.
2005,
44:
3264
5e
Frein JD.
Rovis T.
Tetrahedron
2006,
62:
4573
6
Nasveschuk CG.
Jui NT.
Rovis T.
Chem. Commun.
2006,
3119
7a
Banerji A.
Sarkar M.
Ghosal T.
Pal SC.
Shoolery JN.
Tetrahedron
1984,
40:
5047
7b
Banerji A.
Basu S.
J. Indian Chem. Soc.
1992,
69:
321
For reports that discuss the bioactivity of lignans, see:
8a
Chen I.-S.
Chen J.-J.
Duh C.-Y.
Tsai I.-L.
Phytochemistry
1997,
45:
991
8b
Parmar VS.
Jain SC.
Bisht KS.
Jain R.
Taneja P.
Jha A.
Tyagi OD.
Prasad AK.
Wengel J.
Olsen CE.
Boll PM.
Phytochemistry
1997,
46:
597
9a
Maioli AT.
Civiello RL.
Foxman BM.
Gordon DM.
J. Org. Chem.
1997,
62:
7413
9b
Yoda H.
Kimura K.
Takabe K.
Synlett
2001,
400
10
2-(3,4-Dimethoxyphenyl)-4,7-dihydro[1,3]dioxepine (5): 1H NMR (400 MHz, CDCl3): δ = 7.08-7.02 (2 H, m), 6.84 (1 H, d, J = 8.1 Hz), 5.79 (1 H, s), 5.75 (2 H, s), 4.41-4.19 (4 H, m), 3.88 (3 H, s), 3.86 (3 H, s). 13C NMR (100 MHz, CDCl3): δ = 149.2, 148.9, 131.8, 130.2, 118.9, 110.8, 109.7, 102.3, 64.7, 56.1. IR (NaCl dep. from CHCl3): 2942, 2837, 1516, 1259, 1160, 777 cm-1.
11 For a procedure to prepare 6, see: Scannell RT.
Stevenson R.
J. Heterocycl. Chem.
1980,
17:
1727
12 Vinyl iodide 6 is consumed in these reactions. Small amounts of dioxepin 5 could be re-isolated (ca. 20%).
13
2-(3,4-Dimethoxyphenyl)-5-[1-(3,4,5-trimethoxy-phenyl)vinyl]-4,5-dihydro[1,3]dioxepine (7):
1H NMR (400 MHz, CDCl3): δ = 7.08-7.02 (2 H, m), 6.84 (1 H, d, J = 8.3 Hz), 6.62 (2 H, s), 6.53 (1 H, dd, J = 7.5, 3.0 Hz), 5.49 (1 H, s), 5.38 (1 H, s), 5.19 (1 H, s), 5.01 (1 H, d, J = 7.3 Hz), 4.23 (1 H, d, J = 11.5, 4.5 Hz), 3.94-3.82 (16 H, m), 3.38 (1 H, dd, J = 11.1, 11.1 Hz). 13C NMR (100 MHz, CDCl3): δ = 153.3, 149.6, 149.1, 148.4, 145.3, 138.2, 136.9, 131.6, 118.7, 114.2, 113.3, 110.9, 109.0, 106.4, 103.9, 74.4, 61.1, 56.4, 56.2, 56.1, 46.9. IR (NaCl dep. from CHCl3): 2937, 2836, 1645, 1411, 1128, 732 cm-1. HRMS (+TOF MS): m/z calcd for C24H29O7 [M + H]+: 429.1908; found: 429.1893.
14
Procedure for the Stereoselective Ring Contraction of 7
A flame-dried round-bottomed flask was purged with argon then charged with propionitrile (0.1 M with respect to 1,3-dioxepin) and 0.1 equiv of TMSOTf. The solution was cooled to -78 °C. A separate flame-dried round-bottomed flask was purged with argon and charged with propionitirile (0.1 M with respect to 1,3-dioxepin) and 1 equiv of 7. The solution was then cooled to -78 °C. The solution containing 7 was transferred via cannula to the solution containing Lewis acid at an approximate rate of 1 mL/min. The solution was allowed to mix for 1 h at -78 °C. When the reaction was complete the Lewis acid was quenched with 1 equiv of Et3N and subsequently poured into sat. aq NaHCO3. The aqueous layer was extracted with Et2O (3 ×), then the organic layer was dried with MgSO4. After filtration the solvent removed in vacuo and the crude product was carried through the remainder of the synthetic steps to afford (±)-sylvone 1.
15
(±)-Sylvone (1)
1H NMR (400 MHz, CDCl3): δ = 7.41 (2 H, s), 6.84 (3 H, m), 5.03, (1 H, d, J = 6.0 Hz), 4.43 (1 H, dd, J = 7.9, 7.9 Hz), 4.31 (1 H, ddd, J = 7.7, 5.8, 2.8 Hz), 4.24 (1 H, dd, J = 8.1, 5.8 Hz), 3.96-3.77 (15 H, m), 3.41 (2 H, d, J = 6.4 Hz), 2.89 (1 H, ddd, J = 6.2, 6.0, 2.8 Hz), 1.40 (1 H, br s). 13C NMR (100 MHz, CDCl3): δ = 198.7, 153.3, 149.1, 148.4, 142.9, 131.5, 130.6, 117.9, 111.2, 108.9, 106.4, 81.5, 69.1, 62.1, 61.1, 56.4, 56.0, 56.0, 49.9, 48.9. IR (NaCl dep. from CHCl3): 3516, 2941, 1673, 1516, 1127, 731 cm-1. MS (EI+): m/z calcd for C23H28O8 [M + H]+: 433.2; found: 433.3.